SCHEMBL20162249

SCHEMBL20162249

CCCCCC(=O)/C(=C/c1cc(OC)c(OC)c(OC)c1)C(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.48
▸ HTR2C P28335 3/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ SLC6A4 P31645 1/20 0.48
▸ HTR7 P34969 1/20 0.48
▸ HTR6 P50406 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ CYP3A4 P08684 3/20 0.46
▸ CYP2C19 P33261 3/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ MAPT P10636 3/20 0.45
▸ HTT P42858 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TUBB1 Q9H4B7 4/20 0.40
▸ ALOX5 P09917 2/20 0.40
▸ TOP2A P11388 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20162250 1.00 HTR1A (0.48) HTR1AHTR2CHTR2ASLC6A4HTR7
SCHEMBL20162259 0.91 GAA (0.50) HTR1AHTR2CHTR2ASLC6A4HTR7
SCHEMBL20162262 0.91 GAA (0.50) HTR1AHTR2CHTR2ASLC6A4HTR7
SCHEMBL20162281 0.83 TOP2A (0.41) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL20395699 0.83 MEN1 (0.38) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL20395689 0.83 TOP2A (0.41) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL20162232 0.83 MEN1 (0.38) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL20162235 0.82 CYP3A4 (0.37) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL20395664 0.82 CYP3A4 (0.37) GAATDP1CYP3A4CYP2C19CYP2C9
SCHEMBL9100974 0.81 GAA (0.67) HTR1AHTR2CGAATDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180207080-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS MERCK PATENT GMBH (DE) 2018-07-26 — — US disclosed
EP-3322400-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS Merck Patent GmbH (DE) 2018-05-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180207080-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS LPO, CAT, GPX4 HTR1A 4477/4885HTR2C 4418/4885HTR2A 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback